Lecanemab-irmb Injection

Lecanemab-irmb injection is used to treat Alzheimer’s disease (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and may cause changes in mood and personality) in patients with mild disease. Lecanemab-irmb is in a class of medications called monoclonal antibodies. It works by reducing amyloid beta plaques, abnormal proteins that develop in the brain and contribute to the progression of Alzheimer’s disease.

🔔 How should this medicine be used?

Lecanemab-irmb injection comes as a solution (liquid) to be infused intravenously by a doctor or nurse in a healthcare setting. It is usually given every 2 weeks in an infusion that lasts about an hour.

Lecanemab-irmb injection may cause a severe reaction during or shortly after the infusion of the medication. A doctor or nurse will monitor you carefully while you are receiving the medication. If you experience any of the following symptoms, tell your doctor immediately: fever, chills, body aches, joint pain, nausea, vomiting, dizziness or lightheadedness, feeling of racing heart rate or chest pounding, or difficulty breathing or shortness of breath.

Lecanemab-irmb controls Alzheimer’s disease but does not cure it. Do not stop receiving lecanemab-irmb without talking to your doctor.